Getting (Along) With the Guidelines: Reconciling Patient Autonomy and Quality Improvement Through Shared Decision Making

by Xu, Yan, Wells, Philip S.
Published 2016

Comparing multiple competing interventions in the absence of randomized trials using clinical risk-benefit analysis

by Lazo-Langner, Alejandro, Rodger, Marc A, Barrowman, Nicholas J, Ramsay, Tim, Wells, Philip S, Coyle, Douglas A
Published 2012

Safety and effectiveness of point-of-care monitoring devices in patients on oral anticoagulant therapy: a meta-analysis

by Wells, Philip S, Brown, Allan, Jaffey, James, McGahan, Lynda, Poon, Man-Chiu, Cimon, Karen
Published 2007

Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy

by Wells, Philip S, Gebel, Martin, Prins, Martin H, Davidson, Bruce L, Lensing, Anthonie WA
Published 2014

Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels

by Antoni, Guillemette, Oudot-Mellakh, Tiphaine, Dimitromanolakis, Apostolos, Germain, Marine, Cohen, William, Wells, Philip, Lathrop, Mark, Gagnon, France, Morange, Pierre-Emmanuel, Tregouet, David-Alexandre
Published 2011

Effectiveness of compression stockings to prevent the post-thrombotic syndrome (The SOX Trial and Bio-SOX biomarker substudy): a randomized controlled trial

by Kahn, Susan R, Shbaklo, Hadia, Shapiro, Stan, Wells, Philip S, Kovacs, Michael J, Rodger, Marc A, Anderson, David R, Ginsberg, Jeffrey S, Johri, Mira, Tagalakis, Vicky
Published 2007

Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis

by Castellucci, Lana A, Cameron, Chris, Le Gal, Grégoire, Rodger, Marc A, Coyle, Doug, Wells, Philip S, Clifford, Tammy, Gandara, Esteban, Wells, George, Carrier, Marc
Published 2013

Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban‐treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding

by Kline, Jeffrey A., Jimenez, David, Courtney, D. Mark, Ianus, Juliana, Cao, Lynn, Lensing, Anthonie W.A., Prins, Martin H., Wells, Philip S.
Published 2016

Treatment of Pulmonary Embolism With Rivaroxaban: Outcomes by Simplified Pulmonary Embolism Severity Index Score from a Post Hoc Analysis of the EINSTEIN PE Study

by Fermann, Gregory J, Erkens, Petra M G, Prins, Martin H, Wells, Philip S, Pap, Ákos F, Lensing, Anthonie W A, Kline, Jeffrey
Published 2015

Clinical and Genetic Determinants of Warfarin Pharmacokinetics and Pharmacodynamics during Treatment Initiation

by Gong, Inna Y., Schwarz, Ute I., Crown, Natalie, Dresser, George K., Lazo-Langner, Alejandro, Zou, GuangYong, Roden, Dan M., Stein, C. Michael, Rodger, Marc, Wells, Philip S., Kim, Richard B., Tirona, Rommel G.
Published 2011

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

by Prins, Martin H, Lensing, Anthonie WA, Bauersachs, Rupert, van Bellen, Bonno, Bounameaux, Henri, Brighton, Timothy A, Cohen, Alexander T, Davidson, Bruce L, Decousus, Hervé, Raskob, Gary E, Berkowitz, Scott D, Wells, Philip S
Published 2013

Biodiversity Conservation in the REDD

by Ferry Slik JW, Yaap Betsy, Rafiastanto Andjar, Tan Aseng, Obidzinski Krystof, Marshall Andrew J, Struebig Matthew J, Meijaard Erik, Wells Philip L, Paoli Gary D, Morel Alexandra, Perumal Balu, Wielaard Niels, Husson Simon, D'Arcy Laura
Published 2010-11-01

Long-range epigenetic regulation is conferred by genetic variation located at thousands of independent loci

by Lemire, Mathieu, Zaidi, Syed H.E., Ban, Maria, Ge, Bing, Aïssi, Dylan, Germain, Marine, Kassam, Irfahan, Wang, Mike, Zanke, Brent W., Gagnon, France, Morange, Pierre-Emmanuel, Trégouët, David-Alexandre, Wells, Philip S., Sawcer, Stephen, Gallinger, Steven, Pastinen, Tomi, Hudson, Thomas J.
Published 2015